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ABSTRACT
Introduction: No cases of equine infectious anaemia
(EIA) have been reported in Spain since 1983. Factors
that could increase the risk of reintroducing equine
infectious anaemia virus (EIAV) into Spain include the
recent occurrence of the disease in Europe and the
absence of compulsory serological testing before
importation into Spain.
Aims and objectives: Given the importance of the
Spanish Purebred (SP) horse breeding industry in
Spain, the aim of this cross-sectional study was to
provide evidence of freedom from EIAV in SP stud
farms in Central Spain.
Materials and methods: Serum samples from 555
SP horses, collected between September 2011 and
November 2013, were tested using a commercially
available EIAV ELISA with a published sensitivity of 100
per cent.
Results: All 555 samples were negative for antibody
to EIAV, providing evidence of a true EIAV
seroprevalence between 0 per cent and 0.53 per cent
(95% CIs of the sensitivity and specificity of the ELISA
technique used Q10 were 100 per cent and 99.3 per
cent, respectively) among the SP breeding population
in Central Spain.
Conclusions: These findings should serve to increase
confidence when exporting SP horses to other
countries.
INTRODUCTION
Equine infectious anaemia (EIA) is an
important bloodborne infectious disease of
Equidae caused by equine infectious anaemia
virus (EIAV), an enveloped RNA virus of the
Lentivirus genus of the Retroviridae family
which is distributed worldwide (Cook and
others 2013). EIAV is transmitted mechanic-
ally by haematophagous insects; the most
effective are large biting ﬂies such as Tabanus
several species (horse ﬂy) and Stomoxys calci-
trans (stable ﬂy) (Issel and Foil 1984, Cook
and others 2013). The transmission of the
virus depends on the number and species of
vectors, their feeding habits, the population
density of horses, the level of viraemia in the
host and the amount of blood transferred
(Cook and others 2013). Additionally, EIAV
may also be passed from a mare to her foal
in utero (Stein and Mott 1942, Kemen and
Coggins 1972), iatrogenically by blood trans-
fusions or contaminated needles, surgical
instruments and dental ﬂoats (Williams and
others 1981) and there has been recent evi-
dence of the infection of pulmonary epithe-
lial cells by EIAV suggesting an aerosol
transmission (More and others 2008a,b,
Bolfa and others 2013).
EIA acute clinical disease is characterised
by pyrexia, thrombocytopenia, anaemia,
rapid weight loss, petechiae in the mucous
membranes and oedema and clinically
affected pregnant mares may abort. If death
does not result from the acute clinical infec-
tion, a chronic infection can develop, charac-
terised by the recurrence of febrile episodes.
EIAV infection can also be subclinical and
affected horses do not show obvious clinical
signs (Anon 2013a). The severity of clinical
signs is inﬂuenced by the strain and dose of
the virus and also by the health status of the
horse (Cook and others 2013). Morbidity
and mortality rates vary and mortality rates as
high as 80 per cent have been reported
(Cook and others 2013). The infection rate
varies with the geographical region; infec-
tions are common in humid and swampy
regions (Sellon 1993). In premises where the
disease has been endemic for many years, up
to 70 per cent seroprevalence rates were
observed (Tashjian 1984).
In 1978, an outbreak of EIA started in two
racecourses in Spain. Both racecourses in
Madrid and San Sebastian were quarantined
and nearly 900 Thoroughbred racehorses
were considered at risk until 1983, when the
last outbreak was declared resolved (M
Rodríguez, personal communication January
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15, 2014) and Spain was declared free from EIAV.
Since the EIA outbreak in Ireland in 2006 (More and
others 2008a,b), the disease has affected horses in other
European countries such as France, Germany, the UK,
Greece and Belgium (OIE World Animal Health
Information Database). These outbreaks, along with the
absence of compulsory testing for EIAV before import-
ation from these EU member state countries into Spain
(Council Directive 2009/156/CE) are considered poten-
tially important risk factors for the reintroduction of
EIAV into Spain.
The Spanish Purebred (SP) breed represents 85 per cent
of pure bred horses in Spain and nearly 100 per cent of
Spanish horses are exported to Europe and America, with
this export trade having a monetary value of more than €58
million in 2012 (Anon 2013b). The aim of this cross-
sectional study was to provide evidence for freedom from
EIAV infection in SP horses in stud farms in Central Spain,
thereby enhancing conﬁdence in the export trade of SP
horses.
MATERIALS AND METHODS
Selection of study sample
For the purpose of this study, the central region of
Spain, comprising the provinces of Madrid, Segovia,
Ávila, Cuenca, Guadalajara and Toledo, was chosen.
This area has a population of 21,309 SP horses (based
on 2012 census data) (Anon 2012), a comparable
average density of SP horses with that of Spain (0.39
SP horses/km2 in the central area of Spain v 0.35
SP horses/km2 in the whole of Spain) and a variety of
climate types considered representative of the whole
country (Rubel and Kottek 2010, Anon 2012).
The selection of the study population of SP registered
horses in the central region of Spain was stratiﬁed by
stud farms. In order to capture the heterogeneity of the
SP breeding stud farms, eligible premises were identiﬁed
based on the number of horses and the population
density on the stud farm, the climate of the area (follow-
ing the Köppen–Geiger Climate Classiﬁcation) (Rubel
and Kottek 2010) and geographical distribution within
the central region of Spain. From these premises, a con-
venience sample of stud farms was included, with eli-
gible stud farms recruited consecutively until the target
sample size was reached. Sample size calculations, based
on the population of SP horses in Central Spain, indi-
cated that the minimum number of horses to provide
95% conﬁdence of freedom from EIAV (EIAV seropreva-
lence of less than 1 per cent) in this area was 297
(WinEpi).
Sampling procedures
On every stud farm, 10 ml whole blood samples were
obtained by jugular venepuncture from 100 per cent of
the breeding SP stallions and from at least 25 per cent
of the breeding SP mares by selecting the mares which
were easiest to handle. The inclusion criteria for the
breeding SP stallions and mares were to have actively
bred in the past 12 months or to have been in contact
with other SP breeding stallions/mares, and to be con-
sidered healthy by means of a clinical examination per-
formed by the stud farm veterinary surgeon. Animals
were excluded from the study where it was not possible
to obtain a blood sample due to the animal presenting a
risk for the person in charge of sampling, or where they
were resident on the stud farm for less than three weeks.
Additionally, where possible, blood samples were obtained
from a convenience sample of at least 25 per cent of the
SP colts and ﬁllies aged at least eight months, meeting
the study inclusion criteria and considered to be healthy
by means of a clinical examination performed by the
stud farm veterinary surgeon. For each sampled horse,
data on age, sex and reproductive activity were also col-
lected via an interview questionnaire completed by the
stud farm veterinary surgeon.
Whole blood samples were centrifuged and serum
from each animal was separated using Pasteur pipettes,
identiﬁed with a unique code and stored frozen at −40°
C before being thawed and tested.
Serological analyses
A commercial serological screening kit ELISA
(ID Screen Equine Infectious Anaemia Double Antigen;
ID.Vet Innovative Diagnostics, Montpellier, France) was
used to detect antibodies against the core protein (p26)
antigen of EIAV. This diagnostic kit uses two fragment
antibodies (Fab) on IgG and 10 Fab on IgM which
either bind the immunoglobulins to p26 antigen in the
microplate or bind a peroxidase antigen used as conju-
gate. A weak positive serum from an infected horse in
the EIAV outbreak in 1978 in Madrid was used in con-
junction with positive and negative controls in the kit in
order to validate each kit lot used. According to the
manufacturer’s information, the ELISA kit used in this
study has a published sensitivity and speciﬁcity of 100
per cent; however, in a study of EIAV seroprevalence in
the Sultanate of Oman, the ID Screen Equine Infectious
Anaemia Double Antigen ELISA used in this study was
reported to have a sensitivity of 100 per cent and a speci-
ﬁcity of 99.3 per cent (Body and others 2011). As the
Coggins (agar gel immunodiffusion; AGID) test is the
OIE standard conﬁrmatory test for EIA, any positive or
equivocal samples by ELISA would be tested by Coggins
test.
RESULTS
Between September 2011 and November 2013, serum
samples were obtained from 555 SP horses residing on
35 different stud farms in the central region of Spain
(Fig 1). The proportion of horses sampled in each prov-
ince of this central region broadly matched that of the
2012 census (Anon 2012), as shown in Fig 2.
The size of the horse populations on the 35 participat-
ing stud farms varied from 6 to 220 horses (mean 48.1
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±sd 47.3 horses; median 32 horses, IQR 16–61). The
population density on the stud farms ranged from 0.7 to
630 horses/km2 (mean 80.4 horses/km2±sd 119.8
horses/km2; median 40 horses/km2, IQR 12.1–94.4
horses/km2). The locations of the participating stud
farms in Central Spain were considered to be largely rep-
resentative of the overall Spanish climate; 71 per cent of
the stud farms had a temperate with dry and hot or dry
and temperate summer climate (Csa and Csb,
respectively), these two climates being most commonly
present throughout the country (Rubel and Kottek
2010).
The population of SP horses sampled in this study
included 237 stallions (42.7 per cent) and 318 mares
(57.3 per cent). The mean horse age in the sample
population was 7.3 years±sd 5.0 years (median six years,
IQR 4–10 years). Of the 555 sampled horses, 348
(62.7 per cent) were actively involved in breeding,
FIG 1: Köppen–Geiger climatic map showing the area of study, its different climate types and the distribution of the Spanish
Purebred (SP) stud farms sampled (red points), as well as the location of the equine infectious anemia (EIA) outbreaks in Madrid
between 1978 and 1983 (black star). BSK, cold steppe climate; CFA, temperate with a dry season and hot summer climate; CSA,
temperate with dry or hot summer climate; CSB, temperate with dry or temperate summer climate; DSB, cold with temperate and
dry summer climate.
FIG 2: Distribution by province of 555 Spanish Purebred (SP) horses sampled in Central Spain in comparison with the
distribution of the general SP breeding population in Central Spain published in the census of 2012 (n=21,309)
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whereas 207 (37.3 per cent) were not actively involved in
breeding, including 53 colts (26 per cent) and 28 ﬁllies
(13 per cent), all less than 3 years of age.
After testing the 555 serum samples for antibodies
directed against EIAV proteins by ELISA, all samples
were identiﬁed as negative. Since there were no positive
or equivocal results, no samples were required to be
retested by Coggins test. Based on a census-derived
population size of 21,309 SP breeding horses registered
as of December 31, 2012 in the central area of Spain
(Anon 2012), the sample of 555 SP horses serologically
screened in this study provided evidence with 95% conﬁ-
dence that the true seroprevalence of EIAV among SP
breeding horses in Central Spain was between 0 per
cent and 0.53 per cent (WinEpi).
DISCUSSION
The horse population of the central region of Spain that
was sampled in this study is considered to represent a
high-risk area for the potential introduction of equine
infectious diseases, as horses travelling from/to Europe
frequently stop in this area and it is the region where
the largest number of competitions is held (Anon
2013b). Additionally, the most recent Spanish EIA out-
breaks occurred predominantly in the province of
Madrid (Fig 1), consequently this region was likely to
reﬂect the highest risk of EIAV persistence since 1983,
although no clinical cases of EIA had been detected and
reported through passive surveillance in Spain since
then (OIE World Animal Health Information Database).
The characteristics of the equine population sampled
on the 35 SP stud farms in this study were considered
highly representative of the wider SP breeding horse
population in Central Spain; the proportions of horses
sampled in each province broadly matched those pub-
lished in the census of 2012 (Fig 2), with the highest per-
centages of horses sampled in the provinces with a larger
SP breeding population (Madrid, followed by Toledo and
Segovia) (Anon 2012). The distribution by sex of the
sample was also similar to that described in the census of
2012 for the SP breeding population in the central area
of Spain (47 per cent stallions and 53 per cent mares)
(Anon 2012). Given the excellent representation of the
SP breeding horse population in Central Spain in the
sample population of this study and also the variety of SP
breeding stud farms sampled in terms of size, density of
population and climate, EIAV serological results in this
study can be considered highly representative of the SP
breeding population in Central Spain and could well be
representative of the SP breeding population throughout
Spain, although further studies using a wider sample
population throughout the country would be needed in
order to conﬁrm these ﬁndings.
Although the double-antigen ELISA technique used
to detect antibodies against EIAV in the current study
was not the OIE reference technique (Coggins test),
when testing on a larger scale for screening purposes is
required within a short period of time, ELISA becomes
the test of choice (Paré and Simard 2004, Piza and
others 2007). Some authors have demonstrated a high
degree of agreement between speciﬁc EIAV genetic
material presence and antibodies in equids that are
reported as negative by Coggins test but positive by
ELISA (Issel and others 2013, Scicluna and others
2013); ELISA techniques can detect antibodies directed
against the p26 EIAV-capsid before those detectable by
the Coggins test and overall are considered more sensi-
tive (Soutullo and others 2001, Reis and others 2012).
The reason why the Coggins test is the gold standard
technique for EIA diagnosis is that it is more speciﬁc
(Cullinane and others 2007, Piza and others 2007); that
is, ELISA techniques can result in false positives and
therefore any positive results to EIA detected by ELISA
must be conﬁrmed using the Coggins test (Anon
2013a). In this study, there were no positives to EIAV by
ELISA and therefore there was no requirement to
conﬁrm any samples by Coggins given the excellent sen-
sitivity of the ELISA used (Body and others 2011).
The lack of EIA cases reported in the central region
of Spain during the previous three decades, together
with the absence of any EIAV seropositive animals
detected in the sample population using a highly sensi-
tive ELISA provided 95% conﬁdence that the true preva-
lence of EIAV in the SP breeding population in Central
Spain was up to 0.53 per cent and could be 0 per cent,
conﬁrming freedom from EIAV.
The evidence for freedom from EIAV provided by this
study in SP horses in stud farms in Central Spain may
offer increased conﬁdence when exporting SP horses to
other countries, although judicious biosecurity that
includes both pre-export and post-arrival EIA testing
should be implemented to prevent the movement of
subclinically EIAV-infected horses within Europe.
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